3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 2
1
Status
Unknown
1
Recruiting
1
Sponsor Class
OTHER
112
INDUSTRY
47
NETWORK
6
NIH
3
OTHER_GOV
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
2
Conditions
Colorectal Neoplasms
2
Interventions
Oxaliplatin
30
Capecitabine
26
Fluorouracil
20
Irinotecan
19
tislelizumab
18
apatinib
16
Paclitaxel
13
Cisplatin
13
S 1 (combination)
12
Radiotherapy
12
Leucovorin
11
Bevacizumab
11
Laparoscopy
9
Drug Therapy
9
Cetuximab
9
sintilimab
8
Endoscopic Mucosal Resection
8
Radiation
7
Gemcitabine
7
Docetaxel
7
camrelizumab
6
XELOX
6
Surgical Procedures, Operative
6
Propranolol
6
Nivolumab
6
Neoadjuvant Therapy
6
Immune Checkpoint Inhibitors
6
Folfox protocol
6
Levoleucovorin
5
HMPL-013
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
OTHER_GOV
×
Panitumumab
×
Gastrointestinal
×
Clear all
NCT06226857
2024-01-29
CRC01
City Clinical Oncology Hospital No 1
Phase 3
Recruiting
355 enrolled
NCT03940131
2022-04-06
REPAN
King Abdullah Medical City
Phase 2
Unknown
30 enrolled